July-August 2026 The July issue of Supply Chain Management Review explores how organizations are preparing for the future ...
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results